Barinthus Biotherapeutics

NASDAQ: BRNS · Real-Time Price · USD
1.08
0.01 (0.93%)
At close: Jun 03, 2025, 3:59 PM
1.08
0.00%
After-hours: Jun 03, 2025, 04:04 PM EDT

Barinthus Biotherapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023
License Revenue 14.97M 802K
License Revenue Growth +1766.46% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 12.64M 5.85M 13.42M 5.84M 4.56M 13.73M 961K 13.13M 12.14M 20.31M -10.81M -6.45M 3.66M 9.79M 1.18M 12.37M 1.78M 7.42M 977K 970K 1.11M
Selling, General, and Administrative Revenue Growth +116.12% -56.42% +129.77% +28.04% -66.79% +1329.08% -92.68% +8.16% -40.23% -287.78% +67.80% -275.95% -62.57% +726.52% -90.43% +596.17% -76.06% +659.64% +0.72% -12.77% n/a
Research and Development Revenue 8.29M 4.93M 10.53M 11.68M 11.12M 9.37M 13.94M 12.98M 8.66M 12.1M 10.47M 8.89M 9.65M 5.67M 3.41M 3.63M 3.65M 2.28M 2.09M 3.2M 3.54M
Research and Development Revenue Growth +68.21% -53.20% -9.80% +5.00% +18.60% -32.74% +7.36% +49.98% -28.42% +15.54% +17.70% -7.86% +70.28% +66.15% -6.11% -0.57% +60.61% +8.89% -34.65% -9.76% n/a